SCHEMBL806763

SCHEMBL806763

COc1ncc(-c2ccc3nc(N)c(C(=O)N4CCOCC4)cc3c2)cc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 1/20 0.49
PIK3C3 Q8NEB9 1/20 0.48
PI4KA P42356 1/20 0.47
PIK3CG P48736 1/20 0.47
LRRK2 Q5S007 5/20 0.46
IRAK4 Q9NWZ3 1/20 0.46
NTRK1 P04629 1/20 0.44
GAK O14976 1/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PIK3CD O00329 1/20 0.42
PIK3R1 P27986 1/20 0.42
ALOX5AP P20292 2/20 0.42
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL807059 0.90 PIK3C3 (0.46) PIK3C3PI4KAPIK3CGGAKKDM4E
SCHEMBL10274836 0.90 KCNH2 (0.48) PIK3C3PIK3CGKDM4EALDH1A1HPGD
SCHEMBL807061 0.89 ATR (0.43) KITPIK3C3PI4KAPIK3CGMAPT
SCHEMBL807455 0.83 PI4KA (0.55) PI4KAPIK3CGPIK3CDPIK3R1
SCHEMBL807470 0.82 PIK3CG (0.55) PI4KAPIK3CGPIK3CDPIK3R1
SCHEMBL807137 0.81 PIK3CG (0.75) PI4KAPIK3CGPIK3CDPIK3R1
SCHEMBL807223 0.79 IRAK4 (0.46) KITPI4KAPIK3CGLRRK2IRAK4
SCHEMBL10274687 0.79 PI4KA (0.64) KITPI4KAPIK3CGLRRK2IRAK4
SCHEMBL806789 0.77 PIK3CD (0.50) KITPIK3CGLRRK2IRAK4NTRK1
SCHEMBL10274839 0.76 MAPT (0.56) PI4KAPIK3CGIRAK4PIK3CDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed